BrightPath Biotherapeutics Co., Ltd.
4594.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥810 | ¥1,057 | ¥1,531 | ¥2,305 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥65 | ¥0 | ¥0 | ¥17 |
| Inventory | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Assets | ¥13 | ¥124 | ¥120 | ¥374 |
| Total Curr. Assets | ¥1,071 | ¥1,181 | ¥1,651 | ¥2,696 |
| Property Plant & Equip (Net) | ¥0 | ¥0 | ¥0 | ¥25 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥0 | ¥0 | ¥0 | ¥0 |
| Long-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Tax Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Assets | ¥49 | ¥49 | ¥50 | ¥50 |
| Total NC Assets | ¥49 | ¥49 | ¥50 | ¥75 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥1,121 | ¥1,230 | ¥1,701 | ¥2,771 |
| Liabilities | – | – | – | – |
| Payables | ¥0 | ¥0 | ¥0 | ¥2 |
| Short-Term Debt | ¥25 | ¥113 | ¥0 | ¥88 |
| Tax Payable | ¥0 | ¥13 | ¥10 | ¥39 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥90 | ¥66 | ¥66 | ¥56 |
| Total Curr. Liab. | ¥132 | ¥191 | ¥77 | ¥185 |
| LT Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥64 | ¥60 | ¥57 | ¥55 |
| Total NC Liab. | ¥64 | ¥60 | ¥57 | ¥55 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥196 | ¥251 | ¥134 | ¥240 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥1,200 | ¥651 | ¥362 | ¥6,700 |
| Retained Earnings | -¥3,805 | -¥2,654 | -¥1,486 | -¥10,876 |
| AOCI | ¥22 | ¥23 | ¥20 | ¥23 |
| Other Equity | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥925 | ¥979 | ¥1,568 | ¥2,531 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥1,121 | ¥1,230 | ¥1,701 | ¥2,771 |
| Net Debt | -¥785 | -¥945 | -¥1,531 | -¥2,218 |